Use of basal insulin analog detemir in pregnant women with type 1 diabetes: a case-control retrospective study
Year: 2012
Type: article
Study design: Observational Study
Abstract: Objective. A poor glycemic control during pregnancy is associated with negative pregnancy outcomes and the frequency of pregnancy complications in women with preexisting type 1 diabetes remains high. Our aim was to evaluate retrospectively (years 2006-2011) the effectiveness and safety of insulin detemir vs NPH insulin in women with type 1 diabetes mellitus (T1DM) during pregnancy. \nMethods. Sixteen pregnant T1DM women were included in the study. Among them, 8 maintained the previous therapy with detemir and 8 with NPH. All T1DM patients used short-acting analogs (lispro or aspart) in combination with basal insulin once daily. T1DM pregnant women were evaluated for glycemic status and presence of complications. 43 healthy pregnant women were used as control subjects for fetal and neonatal parameters. Results. No statistically significant differences were detected between detemir and NPH-treated pregnant women. No fetal or neonatal parameters were statistically different in relation to the basal insulin treatment. Conclusions. Insulin detemir is well tolerated as NPH with respect to both maternal parameters in pregnant women and perinatal morbidity and mortality. Although our data need to be confirmed by larger prospective studies, they suggest that insulin detemir represents a valuable option in the management of pregnant women with diabetes.
Institution: University of Palermo
Language: Italian
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1598828120
